BusinessCellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical TrialBy Nasdaq OMXApr 10, 2018, 11:01 AM UTC
BusinessViz Lands $7.5 Million Seed Round to Revolutionize Stroke Care With Artificial IntelligenceBy Nasdaq OMXMay 24, 2017, 11:32 AM UTC
BusinessViz Lands $7.5 Million Seed Round to Revolutionize Stroke Care With Artificial IntelligenceBy Nasdaq OMXMay 24, 2017, 11:32 AM UTC
BusinessViz Lands $7.5 Million Seed Round to Revolutionize Stroke Care With Artificial IntelligenceBy Nasdaq OMXMay 24, 2017, 11:32 AM UTC